Evidence map›Paper›PMID 29437559›Full record

ArticleAnnals of the rheumatic diseases2018

DNA methylation mapping identifies gene regulatory effects in patients with systemic lupus erythematosus.

Juliana Imgenberg-Kreuz, Jonas Carlsson Almlöf, Dag Leonard, Andrei Alexsson, Gunnel Nordmark, Maija-Leena Eloranta, Solbritt Rantapää-Dahlqvist, Anders A Bengtsson, Andreas Jönsen, Leonid Padyukov and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Annals of the rheumatic diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed, 4 pooled it
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 4 syntheses or guidelines pooled it, 168 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. InterferonFrontiers in immunology · 2020
    Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Reduced Methylation of IRF5 Gene as a Biomarker for Gestational Diabetes Mellitus.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 1 country.

Juliana Imgenberg-KreuzDepartment of Medical Sciences, Molecular Medicine and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Jonas Carlsson AlmlöfDepartment of Medical Sciences, Molecular Medicine and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Dag LeonardSection of Rheumatology, Department of Medical Sciences, Uppsala University, Upssala, Sweden.
Andrei AlexssonSection of Rheumatology, Department of Medical Sciences, Uppsala University, Upssala, Sweden.
Gunnel NordmarkSection of Rheumatology, Department of Medical Sciences, Uppsala University, Upssala, Sweden.
Maija-Leena ElorantaSection of Rheumatology, Department of Medical Sciences, Uppsala University, Upssala, Sweden.
Solbritt Rantapää-DahlqvistDepartment of Public Health and Clinical Medicine/Rheumatology, Umeå University, Umeå, Sweden.
Anders A BengtssonDepartment of Clinical Sciences, Section of Rheumatology, Lund University, Skane University Hospital, Lund, Sweden.
Andreas JönsenDepartment of Clinical Sciences, Section of Rheumatology, Lund University, Skane University Hospital, Lund, Sweden.
Leonid PadyukovRheumatology Unit, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Iva GunnarssonRheumatology Unit, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Elisabet SvenungssonRheumatology Unit, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Christopher SjöwallDepartment of Clinical and Experimental Medicine, Rheumatology/Division of Neuro and Inflammation Sciences, Linköping University, Linköping, Sweden.ORCID 0000-0003-0900-2048
Lars RönnblomSection of Rheumatology, Department of Medical Sciences, Uppsala University, Upssala, Sweden.
Ann-Christine SyvänenDepartment of Medical Sciences, Molecular Medicine and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Johanna K SandlingDepartment of Medical Sciences, Molecular Medicine and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Uppsala University · SEKarolinska University Hospital · SELund University · SELinköping University · SEUmeå University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesSystemic lupus erythematosus (SLE) is a chronic autoimmune condition with heterogeneous presentation and complex aetiology where DNA methylation changes are emerging as a contributing factor. In order to discover novel epigenetic associations and investigate their relationship to genetic risk for SLE, we analysed DNA methylation profiles in a large collection of patients with SLE and healthy individuals.

methodsDNA extracted from blood from 548 patients with SLE and 587 healthy controls were analysed on the Illumina HumanMethylation 450 k BeadChip, which targets 485 000 CpG sites across the genome. Single nucleotide polymorphism (SNP) genotype data for 196 524 SNPs on the Illumina ImmunoChip from the same individuals were utilised for methylation quantitative trait loci (

resultsWe identified and replicated differentially methylated CpGs (DMCs) in SLE at 7245 CpG sites in the genome. The largest methylation differences were observed at type I interferon-regulated genes which exhibited decreased methylation in SLE. We mapped

conclusionsOur results suggest that several of the genetic risk variants for SLE may exert their influence on the phenotype through alteration of DNA methylation levels at regulatory regions of target genes.

Indexed as

AdultCase-Control StudiesChromosome MappingCpG IslandsDNA MethylationFemaleGene Expression RegulationGenetic Predisposition to DiseaseGenome-Wide Association StudyGenotypeHumansInterferon Regulatory Factor-1Lupus Erythematosus, SystemicMaleMiddle AgedPolymorphism, Single NucleotideInterferon Regulatory Factor-1gene polymorphismsystemic lupus erythematosus

Identifiers

PMID29437559
PMCPMC5909746
OpenAlexW2787214556

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.